| Basic Materials | -- | |
|---|---|---|
| Consumer Cyclical | -- | |
| Financial Services | -- | |
| Real Estate | -- | |
| Consumer Defensive | -- | |
| Healthcare | -- |
Investing Center Preview – Manage your investments and watch your net worth grow.
BIB:NASDAQ
ProShares Ultra Nasdaq Biotechnology – BIB ETF Overview
| Last Price | Today's Change | 52-Week Range | Trading Volume |
|---|---|---|---|
| 99.23 | -0.32 (-0.32%) | 43.76 - 107.04 | 77.0 thousand (Above Avg) |
Market data as of 4:00PM 05/22/13. Quotes are delayed by at least 15 min.
Overview - BIB
The investment seeks daily investment results that correspond to two times (2x) the daily performance of the Nasdaq Biotechnology Index®. The fund invests in securities and derivatives that ProShare Advisors believes, in combination, should have similar daily return characteristics as two times (2x) the daily return of the index. The index is a modified capitalization weighted index that includes securities of NASDAQ listed companies that are classified as either biotechnology or pharmaceutical according to the Industry Classification Benchmark ("ICB") which also meet other eligibility criteria determined by NASDAQ. The fund is non-diversified.
| Open | 100.75 |
|---|---|
| Previous Close | 99.55 |
| Day's Range | 97.62 - 105.00 |
| Avg Volume (10 Day) | 65.8K |
| Total Assets | $90.21M |
| Expense Ratio | 1.66% |
| Yield (Trailing 12 Mo.) | 0.00% |
| Fund Inception | 04/06/2010 |
Trailing Total Returns - BIB
as of 04/30/2013
| Timeframe | BIB | S&P 500 | Trading-Leveraged Equity |
|---|---|---|---|
| 1 Month | 15.23% | 1.93% | 2.98% |
| 3 Month | 38.53% | 7.18% | 10.09% |
| Year-to-Date | 55.80% | 12.74% | 23.37% |
| 1 Year | 82.93% | 16.89% | 27.68% |
| 3 Year | 45.52% | 12.80% | 14.17% |
| 5 Year | -- | 5.21% | 1.36% |
| 10 Year | -- | 7.88% | -- |
| Since Inception | 43.27% | 10.38% | -- |
Stock Sector Allocation - BIB
as of 04/30/2013
| Utilities | -- | |
|---|---|---|
| Communication Services | -- | |
| Energy | -- | |
| Industrials | -- | |
| Technology | -- |
Top Ten Holdings - BIB
as of 04/30/2013
| Company | YTD Return | % of Assets |
|---|---|---|
| Nasdaq Biotechnology Index Swap Credit Suisse International | -- | 31.21% |
| Ishares Biotech (Ibb) Swap Morgan Stanley & Co. International Plc | -- | 24.91% |
| Nasdaq Biotechnology Index Swap Merrill Lynch International | -- | 22.13% |
| Nasdaq Biotechnology Index Swap Ubs Ag | -- | 22.11% |
| Ishares Biotech (Ibb) Swap Merrill Lynch International | -- | 17.73% |
| Nasdaq Biotechnology Index Swap Societe Generale | -- | 7.35% |
| GILD | 36.53% | 6.10% |
| REGN | 38.71% | 5.85% |
| AMGN | 21.82% | 5.69% |
| CELG | 48.67% | 5.00% |
Valuation & Growth - BIB
as of 04/30/2013
| Valuation | BIB | Category Range |
|---|---|---|
| Price/Earnings | -- | |
| Price/Book | -- | |
| Price/Sales | -- | |
| Price/Cash Flow | -- | |
| Dividend Yield | 0.35 | |
| LT Earnings | 19.06 | |
| Historical Earnings | ||
| Sales Growth | 13.48 | |
| Cash-Flow Growth | 11.82 | |
| Book-Value Growth | 11.18 |
Key: Lo Hi
Morningstar Summary - BIB, 3 Year
| Management Style | |||
|---|---|---|---|
| Large Cap | |||
| Medium Cap | |||
| Small Cap | |||
 |  |  |
| Rating | vs Category | |
|---|---|---|
| Overall | ||
| Risk | ||
| Return |
Key: Lo Hi
Risk Analysis - BIB, 3 Year
| Beta | 1.87 |
|---|---|
| Standard Deviation | 35.59 |
| Alpha | 19.69 |
| Sharpe Ratio | 1.24 |
| Mean | 54.47 |
| R-Squared | 62.19 |
Tax Analysis - BIB, 3 Year Avg
| Pretax Return | 45.52% |
|---|---|
| Tax-adjusted Return | 45.49% |
| Tax Cost Ratio | 0.02% |
| Potential Cap Gains | 36.28% |
- Service & Add-Ons
- Pay bills online
- Online backup services
- Personal credit card
- Quicken merchant services
- Stock quote lookup
- Quicken Community
- Personal finance blog
- Live Community
- YouTube
- Help and Support
- Quicken Support
- Contact us
- Sign In
- My order history
- Investing portfolio